Lajos Pusztai


Ontology type: schema:Person     


Person Info

NAME

Lajos

SURNAME

Pusztai

Publications in SciGraph latest 50 shown

  • 2018-12 CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers in BREAST CANCER RESEARCH
  • 2018-12 Increased epigenetic age in normal breast tissue from luminal breast cancer patients in CLINICAL EPIGENETICS
  • 2018-11 Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-07 Exercise and weight loss interventions and miRNA expression in women with breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-06 Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-04 An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes in BRITISH JOURNAL OF CANCER
  • 2018-04 Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06) in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-03 Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2017-12 Functional germline variants as potential co-oncogenes in NPJ BREAST CANCER
  • 2017-12 Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance in BREAST CANCER RESEARCH
  • 2017-12 Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance in BREAST CANCER RESEARCH
  • 2017-10 Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2017-06-06 Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations in NATURE COMMUNICATIONS
  • 2017-04-20 Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations in NATURE COMMUNICATIONS
  • 2017-04-10 Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer in NATURE COMMUNICATIONS
  • 2016-12 Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer in BREAST CANCER RESEARCH
  • 2016-12 A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer in BMC CANCER
  • 2016-08 SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-01 Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-12 Multigene prognostic tests in breast cancer: past, present, future in BREAST CANCER RESEARCH
  • 2015-12 The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming in NATURE COMMUNICATIONS
  • 2015-12 The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer in SPRINGERPLUS
  • 2015-12 Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-12 Chemotherapy and the recurrence score—results as expected? in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2015-12 Characterization of DNA variants in the human kinome in breast cancer in SCIENTIFIC REPORTS
  • 2015-12 A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients in GENOME MEDICINE
  • 2015-09 Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma in BRITISH JOURNAL OF CANCER
  • 2015-07 A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-06 New targets in breast cancer in MEMO - MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
  • 2015-02 Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-12 Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer in BMC GENOMICS
  • 2014-12 Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-11 Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy in NATURE MEDICINE
  • 2014-10 Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential in BREAST CANCER RESEARCH
  • 2014-09 Unvalidated antibodies and misleading results in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-04 Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-01 Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-01 Ink4a/Arf−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f− quiescent cells in ONCOGENE
  • 2013-12 Reproducibility of research and preclinical validation: problems and solutions in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2013-12 Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers in BREAST CANCER RESEARCH
  • 2013-11 Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing in NATURE BIOTECHNOLOGY
  • 2013-10 Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers in BREAST CANCER RESEARCH
  • 2013-04 A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-04 The prognostic impact of age in patients with triple-negative breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-02 Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas in BRITISH JOURNAL OF CANCER
  • 2013-02 Cancer heterogeneity: implications for targeted therapeutics in BRITISH JOURNAL OF CANCER
  • 2013-01 Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-01 Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-01 High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-12 Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial in BMC MEDICAL GENOMICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.47100.32", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5949.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413559.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.267308.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.139510.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.11598.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21925.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5361.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417307.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419177.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17089.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4989.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.40263.33", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413483.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413558.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419849.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.261356.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.25879.31", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.456130.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.34477.33", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410711.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.15667.33", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411068.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418119.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.462844.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4367.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.433818.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Pusztai", 
        "givenName": "Lajos", 
        "id": "sg:person.01153753137.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153753137.46"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_533.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01153753137.46'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01153753137.46'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01153753137.46'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01153753137.46'


     

    This table displays all metadata directly associated to this object as RDF triples.

    80 TRIPLES      10 PREDICATES      43 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01153753137.46 schema:affiliation Nbbcdffba3e5d4c6ca9d387a8211c0c6a
    2 https://www.grid.ac/institutes/grid.11598.34
    3 https://www.grid.ac/institutes/grid.139510.f
    4 https://www.grid.ac/institutes/grid.14925.3b
    5 https://www.grid.ac/institutes/grid.15667.33
    6 https://www.grid.ac/institutes/grid.17089.37
    7 https://www.grid.ac/institutes/grid.21925.3d
    8 https://www.grid.ac/institutes/grid.240145.6
    9 https://www.grid.ac/institutes/grid.25879.31
    10 https://www.grid.ac/institutes/grid.261356.5
    11 https://www.grid.ac/institutes/grid.267308.8
    12 https://www.grid.ac/institutes/grid.34477.33
    13 https://www.grid.ac/institutes/grid.40263.33
    14 https://www.grid.ac/institutes/grid.410711.2
    15 https://www.grid.ac/institutes/grid.411068.a
    16 https://www.grid.ac/institutes/grid.413483.9
    17 https://www.grid.ac/institutes/grid.413558.e
    18 https://www.grid.ac/institutes/grid.413559.f
    19 https://www.grid.ac/institutes/grid.417307.6
    20 https://www.grid.ac/institutes/grid.417893.0
    21 https://www.grid.ac/institutes/grid.418119.4
    22 https://www.grid.ac/institutes/grid.419177.d
    23 https://www.grid.ac/institutes/grid.419849.9
    24 https://www.grid.ac/institutes/grid.424926.f
    25 https://www.grid.ac/institutes/grid.433818.5
    26 https://www.grid.ac/institutes/grid.4367.6
    27 https://www.grid.ac/institutes/grid.456130.5
    28 https://www.grid.ac/institutes/grid.462844.8
    29 https://www.grid.ac/institutes/grid.48336.3a
    30 https://www.grid.ac/institutes/grid.4989.c
    31 https://www.grid.ac/institutes/grid.5361.1
    32 https://www.grid.ac/institutes/grid.5949.1
    33 https://www.grid.ac/institutes/grid.65499.37
    34 schema:familyName Pusztai
    35 schema:givenName Lajos
    36 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153753137.46
    37 schema:sdDatePublished 2019-03-07T14:48
    38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    39 schema:sdPublisher N477e120f5dbf45a2abdff023741e9a0b
    40 sgo:license sg:explorer/license/
    41 sgo:sdDataset persons
    42 rdf:type schema:Person
    43 N477e120f5dbf45a2abdff023741e9a0b schema:name Springer Nature - SN SciGraph project
    44 rdf:type schema:Organization
    45 Nbbcdffba3e5d4c6ca9d387a8211c0c6a schema:affiliation https://www.grid.ac/institutes/grid.47100.32
    46 sgo:isCurrent true
    47 rdf:type schema:OrganizationRole
    48 https://www.grid.ac/institutes/grid.11598.34 schema:Organization
    49 https://www.grid.ac/institutes/grid.139510.f schema:Organization
    50 https://www.grid.ac/institutes/grid.14925.3b schema:Organization
    51 https://www.grid.ac/institutes/grid.15667.33 schema:Organization
    52 https://www.grid.ac/institutes/grid.17089.37 schema:Organization
    53 https://www.grid.ac/institutes/grid.21925.3d schema:Organization
    54 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    55 https://www.grid.ac/institutes/grid.25879.31 schema:Organization
    56 https://www.grid.ac/institutes/grid.261356.5 schema:Organization
    57 https://www.grid.ac/institutes/grid.267308.8 schema:Organization
    58 https://www.grid.ac/institutes/grid.34477.33 schema:Organization
    59 https://www.grid.ac/institutes/grid.40263.33 schema:Organization
    60 https://www.grid.ac/institutes/grid.410711.2 schema:Organization
    61 https://www.grid.ac/institutes/grid.411068.a schema:Organization
    62 https://www.grid.ac/institutes/grid.413483.9 schema:Organization
    63 https://www.grid.ac/institutes/grid.413558.e schema:Organization
    64 https://www.grid.ac/institutes/grid.413559.f schema:Organization
    65 https://www.grid.ac/institutes/grid.417307.6 schema:Organization
    66 https://www.grid.ac/institutes/grid.417893.0 schema:Organization
    67 https://www.grid.ac/institutes/grid.418119.4 schema:Organization
    68 https://www.grid.ac/institutes/grid.419177.d schema:Organization
    69 https://www.grid.ac/institutes/grid.419849.9 schema:Organization
    70 https://www.grid.ac/institutes/grid.424926.f schema:Organization
    71 https://www.grid.ac/institutes/grid.433818.5 schema:Organization
    72 https://www.grid.ac/institutes/grid.4367.6 schema:Organization
    73 https://www.grid.ac/institutes/grid.456130.5 schema:Organization
    74 https://www.grid.ac/institutes/grid.462844.8 schema:Organization
    75 https://www.grid.ac/institutes/grid.47100.32 schema:Organization
    76 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    77 https://www.grid.ac/institutes/grid.4989.c schema:Organization
    78 https://www.grid.ac/institutes/grid.5361.1 schema:Organization
    79 https://www.grid.ac/institutes/grid.5949.1 schema:Organization
    80 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...